253 related articles for article (PubMed ID: 24445019)
1. Atorvastatin ameliorates contrast medium-induced renal tubular cell apoptosis in diabetic rats via suppression of Rho-kinase pathway.
Su J; Zou W; Cai W; Chen X; Wang F; Li S; Ma W; Cao Y
Eur J Pharmacol; 2014 Jan; 723():15-22. PubMed ID: 24445019
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation.
Morelli A; Chavalmane AK; Filippi S; Fibbi B; Silvestrini E; Sarchielli E; Zhang XH; Vignozzi L; Vannelli GB; Forti G; Maggi M
J Sex Med; 2009 Jan; 6(1):91-106. PubMed ID: 19170840
[TBL] [Abstract][Full Text] [Related]
3. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism.
Zhou S; Zhao P; Li Y; Deng T; Tian L; Li H
Eur J Pharmacol; 2014 Oct; 740():9-14. PubMed ID: 25008071
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin attenuates contrast-induced nephropathy by modulating inflammatory responses through the regulation of JNK/p38/Hsp27 expression.
He X; Li L; Tan H; Chen J; Zhou Y
J Pharmacol Sci; 2016 May; 131(1):18-27. PubMed ID: 27156929
[TBL] [Abstract][Full Text] [Related]
5. Augmenter of liver regeneration attenuates tubular cell apoptosis in acute kidney injury in rats: the possible mechanisms.
Liao XH; Chen GT; Li Y; Zhang L; Liu Q; Sun H; Guo H
Ren Fail; 2012; 34(5):590-9. PubMed ID: 22417144
[TBL] [Abstract][Full Text] [Related]
6. High-dose atorvastatin ameliorates the uterine microenvironment in streptozotocin-induced diabetic rats.
Zeybek B; Ergenoglu M; Erbas O; Yildirim N; Akdemir A; Yavasoglu A; Aktug H; Taskiran D
Gynecol Endocrinol; 2014 Nov; 30(11):789-93. PubMed ID: 24989632
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
Fibbi B; Morelli A; Marini M; Zhang XH; Mancina R; Vignozzi L; Filippi S; Chavalmane A; Silvestrini E; Colli E; Adorini L; Vannelli GB; Maggi M
J Androl; 2008; 29(1):70-84. PubMed ID: 17699803
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin attenuates experimental contrast-induced acute kidney injury: a role for TLR4/MyD88 signaling pathway.
Yue R; Zuo C; Zeng J; Su B; Tao Y; Huang S; Zeng R
Ren Fail; 2017 Nov; 39(1):643-651. PubMed ID: 28805489
[TBL] [Abstract][Full Text] [Related]
9. Rho Kinase Inhibitor, Fasudil, Attenuates Contrast-induced Acute Kidney Injury.
Wang Y; Zhang H; Yang Z; Miao D; Zhang D
Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):278-287. PubMed ID: 28929640
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin post-conditioning attenuates myocardial ischemia reperfusion injury via inhibiting endoplasmic reticulum stress-related apoptosis.
Xia JG; Xu FF; Qu Y; Song DG; Shen H; Liu XH
Shock; 2014 Oct; 42(4):365-71. PubMed ID: 25004060
[TBL] [Abstract][Full Text] [Related]
11. Statin treatment reduces oxidative stress-associated apoptosis of sciatic nerve in diabetes mellitus.
Gürpınar T; Ekerbiçer N; Harzadın NU; Barut T; Tarakçı F; Tuglu MI
Biotech Histochem; 2011 Dec; 86(6):373-8. PubMed ID: 20662602
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats.
Akahori H; Tsujino T; Naito Y; Matsumoto M; Sasaki N; Iwasaku T; Eguchi A; Sawada H; Hirotani S; Masuyama T
J Hypertens; 2014 Jul; 32(7):1534-41; discussion 1541. PubMed ID: 24759122
[TBL] [Abstract][Full Text] [Related]
13. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.
Renke M; Tylicki L; Rutkowski P; Neuwelt A; Larczyński W; Ziętkiewicz M; Aleksandrowicz E; Lysiak-Szydłowska W; Rutkowski B
Acta Biochim Pol; 2010; 57(4):547-52. PubMed ID: 21079818
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin improves survival of implanted stem cells in a rat model of renal ischemia-reperfusion injury.
Cai J; Yu X; Zhang B; Zhang H; Fang Y; Liu S; Liu T; Ding X
Am J Nephrol; 2014; 39(6):466-75. PubMed ID: 24854145
[TBL] [Abstract][Full Text] [Related]
16. Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity.
El-Moselhy MA; El-Sheikh AA
Biomed Pharmacother; 2014 Feb; 68(1):101-10. PubMed ID: 24268999
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin ameliorates tubulointerstitial fibrosis and protects renal function in chronic partial ureteral obstruction cases.
Fitzgerald JP; Chou SY; Franco I; Mooppan UM; Kim H; Saini R; Gulmi FA
J Urol; 2009 Oct; 182(4 Suppl):1860-8. PubMed ID: 19692013
[TBL] [Abstract][Full Text] [Related]
18. Effect of atorvastatin on the angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ) induced diabetic rats.
Chaudagar KK; Mehta AA
Can J Physiol Pharmacol; 2014 Apr; 92(4):338-49. PubMed ID: 24708217
[TBL] [Abstract][Full Text] [Related]
19. Preconditioning with atorvastatin against renal ischemia-reperfusion injury in nondiabetic versus diabetic rats.
Hassan SS; Rizk A; Thomann C; Motawie A; Abdelfattah S; Ahmad Z
Can J Physiol Pharmacol; 2019 Jan; 97(1):1-14. PubMed ID: 30412424
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin inhibits renal crystal retention in a rat stone forming model.
Tsujihata M; Momohara C; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
